Lipid-lowering treatment in peripheral artery disease
- 4 February 2018
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 39, 19-26
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Use of statins in lower extremity artery disease: a reviewBMC Surgery, 2012
- LDL lowering in peripheral arterial disease:are there benefits beyond reducing cardiovascular morbidity and mortality?Clinical Lipidology, 2012
- Peripheral Arterial Disease Is Prevalent But Underdiagnosed and Undertreated in the Primary Care Setting in Central GreeceAngiology, 2012
- The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baselineAtherosclerosis, 2011
- Low-Density Lipoprotein Lowering Does Not Improve Calf Muscle Perfusion, Energetics, or Exercise Performance in Peripheral Arterial DiseaseJACC, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and ManagementMayo Clinic Proceedings, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trialThe Lancet, 2009